Fast and effective topical anaesthetic for procedure pain control.¹²³

LMX4 is a new advanced topical anaesthetic that has an excellent safety profile. LMX4 is used by physicians and health professionals to numb the skin prior to performing cosmetic procedures, collecting blood specimens or placing IV cannulas and such procedures for adults and children 2 years and above.

LMX4 is indicated for “Topical anaesthesia of intact skin prior to superficial skin procedures including IV cannulation and blood sampling”⁹

References
1 Taddio et al, CMAJ 2005; 172(13) 1691-1695
2 Koh et al, Pediatric Anesthesia 2004, 14; 977-982
3 Kleiber et al, Pediatrics vol 100, No 4, October 2002
4 Luhmann et al, Pediatrics, vol 113, No 3, March 2004
5 emla® Australian Product Information May 2008
6 Nestor, Journal of Drugs in Dermatology, July /August 2006, vol 5, issue 7
7 Taddio et al, The Annals of Pharmacology, 2002 April, vol 36
8 Mezei, Drug Permeation Enhancement, 1994, 171-98
9 TGA LMX4 Lidocaine 4% w/w cream May 2010
10 Eichenfield et al, Paediatrics, Vol. 109 No. 6 June 2002
11 RCH Melbourne AnGel Consumer Health Information. 22/11/2002
EMLA® is a registered trademark of AstraZeneca.
Eichenfield et al, Paediatrics, Vol. 109 No. 6 June 2002